Adam Schoenfeld

35PUBLICATIONS
270CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 14, 2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

|May 05, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

|Jan 14, 2026
Timing Is of the Essence: Sequencing Immune Checkpoint Blockade and Radiotherapy for Success in Lung Cancer.

Florence K Keane, Adam J Schoenfeld

Pageof 6

Frequent Collaborators

10 joint publications

Charles M Rudin

8 joint publications

Arielle Elkrief

7 joint publications

Biagio Ricciuti

7 joint publications

Alexander Drilon